Controversies in the adjuvant treatment of breast cancer: new adjuvant endocrine treatment strategies.
Jules Bordet Institute, Brussels, Belgium.
V
V
D'Hondt
M
M
Piccart
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D018579:Patient Selection; D017698:Postmenopause
D018931:Antineoplastic Agents, Hormonal